Hiroaki Wakimoto[Author] - Search Results

Year	Number of Results
2002	3
2003	1
2004	2
2005	1
2006	1
2007	1
2009	4
2010	6
2011	6
2012	8
2013	6
2014	10
2015	6
2016	8
2017	11
2018	11
2019	18
2020	17
2021	13
2022	14
2023	19
2024	12

1

Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors.

Kitagawa Y, Kobayashi A, Cahill DP, Wakimoto H, Tanaka S. Kitagawa Y, et al. Among authors: wakimoto h. Biochim Biophys Acta Rev Cancer. 2024 Apr 21;1879(3):189102. doi: 10.1016/j.bbcan.2024.189102. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2024. PMID: 38653436 Review.

2

Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.

Bommareddy PK, Wakimoto H, Martuza RL, Kaufman HL, Rabkin SD, Saha D. Bommareddy PK, et al. Among authors: wakimoto h. J Immunother Cancer. 2024 Apr 9;12(4):e008880. doi: 10.1136/jitc-2024-008880. J Immunother Cancer. 2024. PMID: 38599661 Free PMC article.

3

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.

Spitzer A, Gritsch S, Nomura M, Jucht A, Fortin J, Raviram R, Weisman HR, Gonzalez Castro LN, Druck N, Chanoch-Myers R, Lee JJY, Mylvaganam R, Lee Servis R, Fung JM, Lee CK, Nagashima H, Miller JJ, Arrillaga-Romany I, Louis DN, Wakimoto H, Pisano W, Wen PY, Mak TW, Sanson M, Touat M, Landau DA, Ligon KL, Cahill DP, Suvà ML, Tirosh I. Spitzer A, et al. Among authors: wakimoto h. Cancer Cell. 2024 Apr 2:S1535-6108(24)00093-X. doi: 10.1016/j.ccell.2024.03.008. Online ahead of print. Cancer Cell. 2024. PMID: 38579724

4

Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of ¹¹C-methionine in IDH-mutant astrocytoma.

Yamamura T, Tamura K, Kobayashi D, Inaji M, Toyama Y, Wakimoto H, Kiyokawa J, Hara S, Tanaka Y, Nariai T, Shimizu K, Ishii K, Maehara T. Yamamura T, et al. Among authors: wakimoto h. J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04661-y. Online ahead of print. J Neurooncol. 2024. PMID: 38557927

5

Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.

Ren L, Xie Q, Deng J, Chen J, Yu J, Wang D, Wakimoto H, Gong Y, Hua L. Ren L, et al. Among authors: wakimoto h. J Neurosurg. 2024 Mar 29:1-9. doi: 10.3171/2024.1.JNS232450. Online ahead of print. J Neurosurg. 2024. PMID: 38552238

6

Chimeric oncolytic adenovirus to break away from neutralizing antibodies.

Sanchez Gil J, Fudaba H, Wakimoto H. Sanchez Gil J, et al. Among authors: wakimoto h. Mol Ther. 2024 Apr 3;32(4):875-877. doi: 10.1016/j.ymthe.2024.03.017. Epub 2024 Mar 20. Mol Ther. 2024. PMID: 38513645 No abstract available.

7

Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma.

Kobayashi A, Kitagawa Y, Nasser A, Wakimoto H, Yamada K, Tanaka S. Kobayashi A, et al. Among authors: wakimoto h. Cells. 2024 Mar 5;13(5):457. doi: 10.3390/cells13050457. Cells. 2024. PMID: 38474421 Free PMC article. Review.

8

Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.

Hua L, Alkhatib M, Fujio S, Alhasan B, Herold S, Zeugner S, Zolal A, Hijazi MM, Clark VE, Wakimoto H, Shankar GM, Brastianos PK, Barker FG, Cahill DP, Ren L, Eyüpoglu IY, Gong Y, Schackert G, Juratli TA. Hua L, et al. Among authors: wakimoto h. J Neurosurg. 2024 Jan 26:1-7. doi: 10.3171/2023.11.JNS231936. Online ahead of print. J Neurosurg. 2024. PMID: 38277657

9

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice.

Liu L, van Schaik TA, Chen KS, Rossignoli F, Borges P, Vrbanac V, Wakimoto H, Shah K. Liu L, et al. Among authors: wakimoto h. Front Immunol. 2024 Jan 11;14:1324618. doi: 10.3389/fimmu.2023.1324618. eCollection 2023. Front Immunol. 2024. PMID: 38274817 Free PMC article.

10

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.

Ren L, Chen J, Deng J, Qing X, Cheng H, Wang D, Ji J, Chen H, Juratli TA, Wakimoto H, Gong Y, Hua L. Ren L, et al. Among authors: wakimoto h. J Neurooncol. 2024 Jan;166(1):59-71. doi: 10.1007/s11060-023-04511-3. Epub 2023 Dec 26. J Neurooncol. 2024. PMID: 38146046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year